We have discussed CNI a number of times over the last year as the position weighed on portfolio performance. Fortunately, we held our nerve, but prudent portfolio management precluded us from increasing our positions. However, we will review our position if/when we see another ~10% on the upside, although its yield is particularly attractive for our Income Portfolio.
- We can see CNI testing above $2 in 2024, but from a risk/reward perspective, this horse has probably bolted – MM holds CNI in our Active Income Portfolio and Emerging Companies Portfolio.
MM is long and bullish toward CNI short term
Add To Hit List
